Pzena Investment Management LLC Raises Stock Holdings in HCA Healthcare, Inc. $HCA

Pzena Investment Management LLC increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 1.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 101,060 shares of the company’s stock after acquiring an additional 1,078 shares during the quarter. Pzena Investment Management LLC’s holdings in HCA Healthcare were worth $43,072,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Clearstead Trust LLC increased its position in HCA Healthcare by 311.8% in the 2nd quarter. Clearstead Trust LLC now owns 70 shares of the company’s stock valued at $27,000 after acquiring an additional 53 shares during the period. Harbor Capital Advisors Inc. raised its stake in shares of HCA Healthcare by 82.9% during the third quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock worth $32,000 after purchasing an additional 34 shares during the last quarter. Twin Peaks Wealth Advisors LLC purchased a new position in HCA Healthcare in the 2nd quarter valued at $40,000. Compound Global Advisors LLC acquired a new stake in shares of HCA Healthcare in the 3rd quarter worth $44,000. Finally, True Wealth Design LLC increased its stake in shares of HCA Healthcare by 179.5% during the third quarter. True Wealth Design LLC now owns 109 shares of the company’s stock worth $47,000 after acquiring an additional 70 shares during the period. 62.73% of the stock is owned by hedge funds and other institutional investors.

HCA Healthcare Price Performance

HCA stock opened at $534.88 on Thursday. HCA Healthcare, Inc. has a 12 month low of $295.00 and a 12 month high of $552.90. The firm has a market capitalization of $119.61 billion, a PE ratio of 18.85, a P/E/G ratio of 1.64 and a beta of 1.36. The company’s 50 day simple moving average is $486.13 and its 200-day simple moving average is $452.76.

HCA Healthcare (NYSE:HCA) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same quarter in the prior year, the firm earned $6.22 EPS. HCA Healthcare’s quarterly revenue was up 6.7% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is currently 10.15%.

Analyst Upgrades and Downgrades

Several equities analysts have issued reports on the company. Cantor Fitzgerald boosted their target price on HCA Healthcare from $525.00 to $588.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 28th. The Goldman Sachs Group increased their price objective on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a research report on Wednesday, January 28th. Zacks Research cut shares of HCA Healthcare from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 27th. KeyCorp set a $503.00 price objective on shares of HCA Healthcare in a report on Wednesday, January 28th. Finally, TD Cowen reiterated a “buy” rating on shares of HCA Healthcare in a research report on Wednesday, January 28th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, HCA Healthcare presently has an average rating of “Moderate Buy” and a consensus price target of $523.27.

Insider Activity

In other news, EVP Michael R. Mcalevey sold 1,694 shares of HCA Healthcare stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Michael S. Cuffe sold 1,500 shares of the firm’s stock in a transaction dated Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. The trade was a 4.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 15,214 shares of company stock valued at $7,797,595. 1.30% of the stock is owned by corporate insiders.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA opened a second freestanding emergency room in a Florida county (St. Augustine), expanding local access and potential outpatient/ER revenue streams as the company pushes more care into lower-acuity, higher-margin settings. Becker’s: HCA opens 2nd freestanding ER in Florida county MSN: HCA Florida Emergency opens for patients in St. Augustine
• Positive Sentiment: An HCA subsidiary acquired a cardiothoracic and vascular physician group, a deal that should boost patient referrals into HCA hospitals, increase capture of surgical volume, and support revenue growth in high-acuity service lines. Becker’s: HCA subsidiary acquires cardiothoracic, vascular physician group
• Positive Sentiment: HCA is investing in EHR unification (alongside peers), an initiative that can lower IT/operational costs, improve care coordination and billing efficiencies — all supportive of margins over time. Becker’s: Why Northwell, HCA and UPMC are betting big on EHR unification
• Positive Sentiment: Analyst/style coverage and positive momentum stories (Zacks, Kalkine) highlight HCA as a value/momentum name, which can attract income/value-oriented and momentum-driven flows. Zacks: Here’s Why HCA Healthcare is a Strong Value Stock Kalkine: HCA Momentum Shines
• Neutral Sentiment: Discussion pieces and analyst roundups examine where HCA shares may head next; these provide context but are unlikely to move the stock materially absent new guidance or earnings surprises. Yahoo Finance: Are Wall Street Analysts Predicting HCA Stock Will Climb or Sink?
• Neutral Sentiment: Local community/CSR activity (National Wear Red Day with Habitat for Humanity) is positive for brand and community relations but has limited direct impact on near-term financials. Post and Courier: HCA marks National Wear Red Day
• Negative Sentiment: An HCA EVP, Michael R. McAlevey, disclosed a sale of 1,694 shares for about $903k, reducing his holdings ~16% — insider selling can signal personal liquidity needs but may create short-term negative sentiment for investors reading into insider actions. SEC filing: SEC filing: Insider sale

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.